UNSPSC 51422322: Betamethasone acetate

This classification denotes a therapeutic glucocorticoid with the molecular formula C24H31FO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TI05AO53L7, chemically known as pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-9-fluoro-11,17-dihydroxy-16-methyl-, (11.beta.,16.beta.)- but more generally known as betamethasone acetate, which bears US NIH Compound Identifier 3680.

UNSPSC 51422322 Betamethasone acetate is a Commodity code that nominally designates pharmaceutical compounds, but the recent state and local procurement activity under this code shows little alignment with that scope. Seminole County, Florida, a county government, posted an IFB in June 2026 for naloxone and safe drug deactivation systems—neither of which are betamethasone acetate or related corticosteroids. The mismatch suggests either a coding error in the county's tagging or that this UNSPSC category may not be the active marketplace for betamethasone procurement at the state and local level.

The single recent opportunity on file—Seminole County's IFB 60459723LAS, with a response deadline of July 26, 2023, for 1,900 units of naloxone and 800 safe drug deactivation systems annually—does not represent meaningful activity in the betamethasone acetate commodity space. The source provides no evidence of substantive recent state or local procurement volume under this code, no geographic concentration of activity across multiple jurisdictions, and no pattern of repeat buyers. Absent clearer alignment between the code's pharmaceutical scope and actual state and local solicitations, this code warrants close monitoring but shows no current procurement signal worth pursuing.